Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations
Introduction
Despite the large number of genetic association studies that have been published over the last decade, there has been a lack of consensus regarding the role of common genomic variation in the genetic susceptibility to atherosclerosis and its related intermediate phenotypes [1]. Almost no allele of any gene studied to date has been shown to be consistently associated with variation in intermediate phenotypes of atherosclerosis, such as plasma lipoproteins, across diverse populations [2], [3]. Part of the inconsistency may be due to the fact that many of the DNA markers studied do not have a functional impact on the structure or expression of the gene product. Thus, most positive associations have been attributed to linkage disequilibrium with putative functional changes elsewhere at the genetic locus. Since linkage disequilibrium may vary between populations, factors such as admixture can produce falsely positive genetic associations [3], [4]. One way to reduce such confounding effects would include selecting DNA markers that directly mark a functional change in the gene of interest. Also, consistent results from complementary experimental evidence, such as using independent statistical approaches, independent study samples, in vitro studies and/or animal studies may increase confidence in the biological validity of genetic associations.
Recently, several groups have reported an association between variation in plasma biochemical traits and variation in the promoter sequence of the LIPC gene, which encodes hepatic lipase (HL) [5], [6], [7], [8], [9]. The associations were found with a C->T nucleotide change at position -480, or -514, depending upon the nucleotide taken as the transcription start site [10]. The most striking finding from these studies was a significantly lowered post-heparin HL activity associated with the -480T allele, with -480C/C homozygotes having the highest post-heparin HL activity, C/T heterozygotes having reduced levels (by ∼25%) and -480T/T homozygotes having the lowest levels (by ∼50%) [7], [8]. In addition, some of these groups also reported associations with plasma lipoprotein traits. For example, among 270 Finnish subjects, 16 were -480T/T homozygotes: these -480T/T subjects had significantly higher (by ∼10%) plasma HDL cholesterol and apolipoprotein (apo) AI compared with subjects with other genotypes [5]. Among 612 Dutch males, 11 were -480T/T homozygotes: these -480T/T subjects had significantly higher (by ∼15%) plasma HDL cholesterol compared with subjects with other genotypes [7]. Among 133 males from Dallas, 30 -480C/T heterozygotes and 2 -480T/T homozygotes, respectively, had significantly higher (by ∼10% and ∼50%) HDL cholesterol and apo AI than 101 -480C/C homozygotes [6]. In contrast, among 395 Finnish males, 26 -480T/T homozygotes did not have significantly different plasma HDL cholesterol compared with subjects with other genotypes [8]. Finally, it was recently suggested that the higher plasma HDL cholesterol in African American males compared with white Americans was related to a higher frequency of the LIPC -480T allele and, in particular, a higher frequency of LIPC -480T/T homozygotes in this ethnic group [9]. We report an association analysis between the LIPC promoter variant and plasma lipoproteins in samples taken from three distinct and independent Canadian populations: Alberta Hutterites, Sandy Lake Oji-Cree and Keewatin Inuit.
Section snippets
Hutterites
846 individuals from 21 colonies of Alberta Hutterites aged from 18 to 80 years participated in the Canadian Heart Health Survey for CHD risk assessment [11], [12], [13], [14], [15], [16], [17]. These individuals came from two sects, called Lehrerleut and Dariusleut [11], [12], [13], [14], [15], [16], [17]. Almost every one of the study subjects could be placed into a defined sibship representing one of 187 nuclear families. The average inbreeding coefficient for members of the study sample was
Baseline clinical and biochemical characteristics
A summary of the clinical and biochemical characteristics of the three study samples is shown in Table 1. While the mean ages of male and female Hutterites and Inuit were not different, both were significantly higher than those in male and female Oji-Cree (P<0.01). While the mean BMI of male and female Oji-Cree and Inuit were not different, both were significantly lower than those in male and female Hutterites (P<0.01). There were differences between the three study samples with respect to
Discussion
In this study of independent samples taken from three distinct Canadian populations, with a wide range of allele frequencies of the LIPC promoter polymorphism, we found no association between variation in the LIPC promoter and lipoprotein phenotypes between or within populations. Specifically, there was no association of the LIPC -480T allele, or of homozygosity for the LIPC -480T allele, and elevated plasma HDL cholesterol concentration in either men or women from any of the three study
Acknowledgements
We acknowledge the cooperation and assistance from: the Hutterite communities and the sample collectors from the Canadian Heart Health Surveys; the chief and council of the community of Sandy Lake; the Sandy Lake community surveyors; the Sandy Lake nurses and the staff of the University of Toronto Sioux Lookout program; and the members of the Health Canada research team. This work was supported by grants from the National Institutes of Health (1-R21-DK44597-01), the Ontario Ministry of Health
References (36)
- et al.
Hepatic lipase activity is lower in African American men than in white American men: effects of the 5′ flanking polymorphism in the hepatic lipase gene
J Lipid Res
(1998) - et al.
Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes
Lancet
(1997) - et al.
A common mtDNA polymorphism associated with variation in plasma triglyceride concentration
Am J Hum Genet
(1997) - et al.
V677 mutation of methylene-tetrahydrofolate reductase and cardiovascular disease in Canadian Inuit
Lancet
(1997) - et al.
A compound heterozygote for hepatic lipase gene mutations Leu334->Phe and Thr383->Met: correlation between hepatic lipase activity and phenotypic expression
J Lipid Res
(1996) - et al.
Heterozygous hepatic lipase deficiency due to two missense mutations R186H and L334F in the HL gene
Atherosclerosis
(1997) - et al.
A novel A->G mutation of intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency
J Lipid Res
(1996) - et al.
Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity
J Lipid Res
(1998) - et al.
The clinical investigator: bewitched, bothered, and bewildered—but still beloved
J Clin Invest
(1997) - et al.
Genetic markers for atherosclerosis and related risk factors
Candidate genes, small effects, and the prediction of atherosclerosis
Crit Rev Clin Lab Sci
Genetic dissection of complex traits
Science
A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol
Proc Natl Acad Sci USA
Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients
Arterioscler Thromb Vasc Biol
Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Investigators
J Clin Invest
Structure of the human hepatic triglyceride lipase gene
Biochemistry
A polymorphism of the angiotensinogen gene is associated with variation in blood pressure in a genetic isolate
Circulation
Cited by (55)
The Genetics of Cardiovascular Disease in Canadian and International Aboriginal Populations
2015, Canadian Journal of CardiologyCitation Excerpt :Risk factors for susceptibility to diabetes overlap with CVD, therefore, several of the studies carried out also had implications for CVD risk. For instance, directed association studies for single nucleotide polymorphisms in genes implicated for processes involved in CVD risk such as hypertension (angiotensinogen [AGT] T-6A67), lipid metabolism (lipase, hepatic [LIPC] -480T56; apolipoprotein [APO]C3 -455T and APOE∼ E454; cholesterol 7 alpha-hydroxylase [CYP7] -278A59), including plasma triglycerides (fatty acid binding protein 2, intestinal [FABP2] A54T55), and cholesterol (paraoxonase 1 [PON1] Q192R69) were carried out. Studies on genetic susceptibility to carotid intima-media thickness,62 peripheral vascular disease (methylenetetrahydrofolate reductase [NAD(P)H] [MTHFR] C677T),63 and body mass index (BMI) (adrenoceptor beta 3 [ADRB3] Y64R)64 have also been conducted.
Association of the -250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients
2008, Journal of Diabetes and its ComplicationsCitation Excerpt :However, it cannot be explained by the effect of the -250A allele on the lipid variables studied, as we found no differences in the levels of HDL cholesterol or in the content of small, dense LDL cholesterol when the carriers of the -250A allele were compared with the noncarriers. This is in agreement with other studies on diabetic persons (Hegele et al., 1999). Of special note is the fact that dietary fats, among other factors, interact with SNP in modulating the levels of HDL cholesterol (Corella & Ordovas, 2005).
-250G/A LIPC polymorphism and its relationship with peripheral artery disease in type 2 diabetic patients
2008, Clinica e Investigacion en ArteriosclerosisAge-dependent association between hepatic lipase gene C-480T polymorphism and the risk of pre-hospital sudden cardiac death: The Helsinki Sudden Death Study
2007, AtherosclerosisCitation Excerpt :The T allele has been found to associate with lower HL activity [10–13]. The findings of the association between the T allele and HDL cholesterol as well as total cholesterol concentration have been inconsistent [10,11,13–17]. In a recent meta-analysis [18], however, carriers of the TT genotype had an elevated total and HDL cholesterol level.